Is gene therapy the next big step in vision loss treatment?

Translate to Spanish or other 102 languages!

An increasing number of clinical trials are exploring the ways in which gene therapy could treat different forms of vision loss. Image for illustration purposes
An increasing number of clinical trials are exploring the ways in which gene therapy could treat different forms of vision loss. Image for illustration purposes
- Advertisement -

An increasing number of clinical trials are exploring the ways in which gene therapy could treat different forms of vision loss. Image credit: Liliya Rodnikova/Stocksy.

Gene therapy uses genetic material, either DNA or RNA, to treat or prevent the progression of a disease. It often involves the introduction of genetic material into a person’s cells to replace a defective or missing gene. 

Although early attempts at gene therapy have been effective in achieving the expression of the therapeutic gene in the target tissue, they have also been accompanied by severe adverse effects.

- Advertisement -

Follow the link below to Medical News Today to read he full story:

https://www.medicalnewstoday.com/articles/is-gene-therapy-the-next-big-step-in-vision-loss-treatment?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-10-01&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Study: Supplement Plus Chemo Boosts Pancreatic Cancer Survival

L-glutamine, an amino acid that occurs naturally in the body and plays an important role in digestion, has been studied as a potential way to ease side effects in other cancers.

How Artificial Intelligence Is Improving Prostate Cancer Diagnostics

Mega Doctor News CLEVELAND CLINIC - September is Prostate Cancer Awareness Month.  Prostate cancer is...

New Strategies to Soothe Dry Eyes

Anyone who has ever endured burning, itchy eyes or extra tearing knows that these symptoms are tough to ignore.

FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder

The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.
- Advertisement -